PATLY.AIApplication
19621471 · ERBB-2 AND ERBB3 TARGETING AGENTS FOR USE IN THE TREATMENT OF MALIGNANT CELLS OR CANCERS THAT HAVE ELEVATED NRG1 EXPRESSION
Filed 2026-09-04 · Pending The official file ↗ · Art unit · MERUS B.V. · STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C.
Office actions
0
first was
RCEs
0
no appeal
To first action
n/a
to disposition n/a
Statutes raised
·
0 actions read